Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.1 USD | +1.40% | -3.26% | -19.30% |
Financials (USD)
Sales 2024 * | 691M | Sales 2025 * | 729M | Capitalization | 781M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.07 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3,771 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.15% |
Latest transcript on Avanos Medical, Inc.
1 day | +1.40% | ||
1 week | -3.26% | ||
Current month | -9.09% | ||
1 month | -9.05% | ||
3 months | -5.53% | ||
6 months | +1.63% | ||
Current year | -19.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Woody
CEO | Chief Executive Officer | 58 | 17-06-25 |
Michael Greiner
DFI | Director of Finance/CFO | 51 | 19-12-31 |
Compliance Officer | - | 20-09-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
CHM | Chairman | 66 | 14-10-30 |
Patrick O'Leary
BRD | Director/Board Member | 66 | 14-10-30 |
Julie Shimer
BRD | Director/Board Member | 71 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 27 M€ | -5.03% | - | |
0.19% | 45 M€ | +0.20% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 18.1 | +1.40% | 133,303 |
24-04-25 | 17.85 | -4.60% | 230,915 |
24-04-24 | 18.71 | -0.27% | 169,979 |
24-04-23 | 18.76 | -1.00% | 125,765 |
24-04-22 | 18.95 | +1.28% | 185,786 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.30% | 781M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- AVNS Stock